Search

Your search keyword '"Santacana, Maria"' showing total 126 results

Search Constraints

Start Over You searched for: Author "Santacana, Maria" Remove constraint Author: "Santacana, Maria" Database Unpaywall Remove constraint Database: Unpaywall
126 results on '"Santacana, Maria"'

Search Results

31. Supplementary Tables 1-2 from Immune-Dependent and Independent Antitumor Activity of GM-CSF Aberrantly Expressed by Mouse and Human Colorectal Tumors

32. Data from Immune-Dependent and Independent Antitumor Activity of GM-CSF Aberrantly Expressed by Mouse and Human Colorectal Tumors

33. Data from Immune-Dependent and Independent Antitumor Activity of GM-CSF Aberrantly Expressed by Mouse and Human Colorectal Tumors

34. Supplementary Figures 1-10 from Immune-Dependent and Independent Antitumor Activity of GM-CSF Aberrantly Expressed by Mouse and Human Colorectal Tumors

35. Supplementary Figures 1-10 from Immune-Dependent and Independent Antitumor Activity of GM-CSF Aberrantly Expressed by Mouse and Human Colorectal Tumors

36. Supplementary Tables 1-2 from Immune-Dependent and Independent Antitumor Activity of GM-CSF Aberrantly Expressed by Mouse and Human Colorectal Tumors

37. Oxidative stress‐induced FAK activation contributes to uterine serous carcinoma aggressiveness

38. Generation and Integrated Analysis of Advanced Patient‐Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial Cancer

39. Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer

41. ARID1A ‐deficient cells require HDAC6 for progression of endometrial carcinoma

42. Differential Immunoexpression of BRAF/V600E, Senescence Markers, PTEN, and T-type Calcium Channels in Acquired Naevi According to their Histopathological and Dermoscopic Classification

43. CD44-negative parietal–epithelial cell staining in minimal change disease: association with clinical features, response to corticosteroids and kidney outcome

44. BRAFV600E Mutant Allele Frequency (MAF) Influences Melanoma Clinicopathologic Characteristics

45. M-TRAP: Safety and performance of metastatic tumor cell trap device in advanced ovarian cancer patients

46. The cutoff for estrogen and progesterone receptor expression in endometrial cancer revisited: a European Network for Individualized Treatment of Endometrial Cancer collaboration study

48. An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study

49. Developing indicators for quality assurance in cytopathology. Catalan Society of Cytopathology

50. Comprehensive Constitutional Genetic and Epigenetic Characterization of Lynch-Like Individuals

Catalog

Books, media, physical & digital resources